Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Edasalonexent | Edasalonexent, also known as CAT-1004, is a NF-kappa B inhibitor under the development of Catabasis Pharmaceuticals and Sarepta Therapeutics. It is a Inflammation mediator inhibitor and could be an anti-inflammatory drug candidate. In Apr 2016, Phase-II clinical trials in Duchenne muscular dystrophy (In children) in USA were on-going. In Sep 2016, Catabasis Pharmaceuticals and Sarepta Therapeutics agreed to co-develop edasalonexent with an exon skipping treatment together in USA for Duchenne muscular dystrophy. Uses: Anti-inflammatory; duchenne muscular dystrophy. Synonyms: CAT-1004; CAT1004; CAT 1004; Edasalonexent; Sodium salicylate-docosahexaenoic acid conjugate;N-(2-((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenamido)ethyl)-2-hydroxybenzamide. Grades: 98%. CAS No. 1204317-86-1. Molecular formula: C31H42N2O3. Mole weight: 490.69. |  |
| Edasalonexent | Edasalonexent (CAT-1004) is an orally bioavailable NF-κB inhibitor. Uses: Scientific research. Group: Signaling pathways. Alternative Names: CAT-1004. CAS No. 1204317-86-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-17630. |  |
Our database is helping our users find suppliers everyday.
